Searched for
INDIANS INVESTING IN THE US
Sensex drops 364 points, Nifty closes below 23,900 as market falls for 4th day on rising Iran-US tensions. What’s ahead?Indian stock markets extended losses for a fourth session on Thursday. Sensex and Nifty closed lower as oil prices soared significantly. Br...
FCNR (B) vs NRE 5-year FD: Which can give higher maturity on $50,000 investment? Know currency riskFCNR(B) vs NRE currency risk: FCNR(B) and NRE deposits offer distinct investment avenues for non-resident Indians. FCNR(B) deposits provide...
FAR bonds lose their pull as tailwinds fadeForeign inflows into Indian government securities have begun to slow down. This moderation follows a strong surge in June driven by index i...
Temasek doubles down on India; sees long-term opportunities in family businessesTemasek International sees family businesses opening to investors as a major market shift. Generational transitions create attractive long-...
Singapore's Temasek joins race for a slice of the $18.5 billion IPLSingapore's Temasek is exploring investment opportunities within India's Indian Premier League. The league attracts sovereign wealth funds ...
Tariffs alone will not produce sustainable generic medicine in US: IPAThe Indian Pharmaceutical Alliance believes tariffs alone will not build US generic drug manufacturing. Broader reforms are needed for fair...
Indian pharma firms may yet survive Trump's 200% tariff bombshellDonald Trump's proposed up to 200% tariff on generic drug imports has raised concerns for Indian pharma companies, but industry experts say...
Trump's 200% drug tariff plan: Is India's pharma industry about to face an economic storm?The United States is set to implement a phased approach to tariffs on generic drug imports, beginning at zero percent and escalating to one...
Trump announces new generic drugs tariff plan: No tariffs for 2 years, then 100%, and then 200%For Indian exporters, the two-year tariff-free period offers additional time to reassess supply chains and investment plans. While the imme...
Sun Pharma, Cipla & other pharma stocks shed over 2% as Trump announces up to 200% tariffs on generic drugs from 2028Pharma stocks, including Sun Pharma, Cipla, Lupin and Dr Reddy's, fell up to 2.5% after US President Donald Trump announced a phased tariff...
Lakshmi Mittal family-backed Amit Bhatia-led group eyes stake in $6 bn Liverpool FC: ReportA consortium led by Amit Bhatia is reportedly in talks to acquire a significant minority stake in Liverpool FC. This potential deal could v...
Indian professionals are turning to EB-5 as decades-long green card waits make H-1Bs untenableThe US EB-5 Immigrant Investor Program is increasingly being used by Indian professionals trapped in decades-long employment-based green ca...
India engaged with the US, studying all the developments: Govt tells ParliamentThe government told Parliament it is closely monitoring developments in its trade relationship with the US and remains engaged with Washing...
Japan's SOMPO seeks control of Universal GeneralJapan's SOMPO Insurance is discussing increasing its stake in Universal SOMPO General Insurance. The Japanese insurer aims to acquire share...
FCNR scheme: Withholding tax fear haunts US, Singapore NRIsNon-resident Indians residing in Singapore and the United States are expressing significant concerns over withholding taxes. These taxes th...
India vs US real estate: Transparency, legal protection, fraud risks, and what NRIs should consider before buying propertyIt is relatively easier to reliably buy or sell property in the United States, compared to the process in India, which can be fraught with ...
NRI insurance: Benefits, risks, and features of GIFT City’s dollar-denominated insurance plansMany companies—including HDFC Life International, ICICI Prudential Life, ICICI Lombard, Star Union Dai-ichi Life, IndiaFirst Life and Tata-...